Literature DB >> 5950679

Interactions of cheese and of its constituents with monoamine oxidase inhibitors.

B Blackwell, E Marley.   

Abstract

Mesh：

Substances：

Year:  1966        PMID： 5950679      PMCID： PMC1510784          DOI： 10.1111/j.1476-5381.1966.tb01816.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN： 0366-0826


× No keyword cloud information.
  11 in total

1.  MONOAMINE OXIDASE INHIBITORS, TYRAMINE, AND CHESSE.

Authors:  D HORWITZ; W LOVENBERG; K ENGELMAN; A SJOERDSMA
Journal:  JAMA       Date:  1964-06-29       Impact factor: 56.272

2.  MONOAMINE OXIDASE INHIBITORS: AUGMENTATION OF PRESSOR EFFECTS OF PERORAL TYRAMINE.

Authors:  D H TEDESCHI; E J FELLOWS
Journal:  Science       Date:  1964-06-05       Impact factor: 47.728

3.  CHEESE AND MONOAMINE OXIDASE INHIBITORS. INTERACTION IN ANAESTHETISED CATS.

Authors:  I L NATOFF
Journal:  Lancet       Date:  1964-03-07       Impact factor: 79.321

4.  INTERACTION BETWEEN CHEESE AND MONOAMINE-OXIDASE INHIBITORS IN RATS AND CATS.

Authors:  B BLACKWELL; E MARLEY
Journal:  Lancet       Date:  1964-03-07       Impact factor: 79.321

5.  TRANYLCYPROMINE AND CHEESE.

Authors:  A M ASATOOR; A J LEVI; M D MILNE
Journal:  Lancet       Date:  1963-10-05       Impact factor: 79.321

6.  HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS.

Authors:  B BLACKWELL
Journal:  Lancet       Date:  1963-10-26       Impact factor: 79.321

7.  The presence and distribution of tyramine in mammalian tissues.

Authors:  S SPECTOR; K MELMON; W LOVENBERG; A SJOERDSMA
Journal:  J Pharmacol Exp Ther       Date:  1963-05       Impact factor: 4.030

8.  Effect of amine oxidase inhibitors on the noradrenaline and adrenaline content of cat organs.

Authors:  U S VON EULER; S HELLNER-BJORKMAN
Journal:  Acta Physiol Scand Suppl       Date:  1955

9.  Amine oxidase and amine metabolism.

Authors:  H BLASCHKO
Journal:  Pharmacol Rev       Date:  1952-12       Impact factor: 25.468

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  12 in total

1.  The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder.

Authors:  Lois Jessen; Lawrence J Kovalick; Albert J Azzaro
Journal:  P T       Date:  2008-04

2.  [Interactions between nutrition and drugs].

Authors:  G Czok
Journal:  Z Ernahrungswiss       Date:  1976-06

3.  Tryptamines and spinal cord reflexes in cats.

Authors:  E Marley; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-11

Review 4.  Clinically significant drug interactions with antidepressants in the elderly.

Authors:  Edoardo Spina; Maria Gabriella Scordo
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Concepts, problems and the role of modifying agents in the relationship between recovery of cells' survival ability and mechanisms of repair of radiation lesions.

Authors:  J S Orr
Journal:  Br J Cancer Suppl       Date:  1984

6.  Interactions of yeast extracts and their constituents with monoamine oxidase inhibitors.

Authors:  B Blackwell; E Marley
Journal:  Br J Pharmacol Chemother       Date:  1966-01

7.  limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.

Authors:  Shunit Gal; Zaid A Abassi; Moussa B H Youdim
Journal:  Neurotox Res       Date:  2009-11-06       Impact factor: 3.911

8.  [Inhibition of monoamine oxidase and diamine oxidase by furazolidone (Furoxon). Pharmacologic and biochemical studies in man].

Authors:  D Palm; U Magnus
Journal:  Klin Wochenschr       Date:  1968-07-01

Review 9.  Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK.

Authors:  A R Green
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

10.  A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression.

Authors:  Larry Culpepper; Lawrence J Kovalick
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.